Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Water | HCID 962 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | L-Proline | HCID 145742 | — |
| Reactant | HCID 178526491 | HCID 178526491 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 67089020 | HCID 67089020 | 46% |
Reaction Steps
Imidazole (280 mg, 4.1 mmol), potassium carbonate (1.40 g, 10 mmol), L-proline (95 mg, 0.82 mmol), and cuprous iodide (78 mg, 0.41 mmol) were added to 3-bromo-5-nitro-pyrazolopyridine (500 mg, 2.1 mmol) in DMSO (5 mL). The resulting mixture was heated in a sealed vial at 110° C. overnight. The reaction mixture was diluted with water and 10% isopropyl alcohol (“IPA”)/DCM. The resulting slurry was filtered through celite, and the layers were separated. The aqueous layer was extracted with another portion of 10% IPA/DCM. The combined organic layers were washed twice with brine, dried over magnesium sulfate, filtered, and evaporated to yield 3-(1H-imidazol-1-yl)-5-nitro-1H-pyrazolo[3,4-b]pyridine (220 mg, 46% yield) as a solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08394795B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-cfa48b1f17e845dfb427b801578a75a5 |
|---|
| Source note | uspto-grants-2013_03 |
|---|